CancerPPD

This page gives details of Query peptides and provides facility to browse the same in CancerPPD database. Please wait while data is being retrieved. For more information see HELP page.

ID	PMID	SEQUENCE	NAME	LENGTH	ACTIVITY
1076	18617323	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	IC₅₀=12.4 µg/ml
1077	18617323	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	IC₅₀=12.9 µg/ml
1078	18617323	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	IC₅₀=9.5 µg/ml
1079	18617323	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	IC₅₀=13.8 µg/ml
1080	18617323	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	IC₅₀=15.5 µg/ml
1081	18617323	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	IC₅₀=10.6 µg/ml
1111	16572423	FKCRRWQWRMKKLGA	Lactoferricin B	15	IC₅₀=15.5 µM
1112	16572423	FKCRRWQWRMKKLGA	Lactoferricin B	15	IC₅₀=29 µM
1113	16572423	FKCRRWQWRMKKLGA	Lactoferricin B	15	IC₅₀=37 µM
1114	16572423	FKCRRWQWRMKKLGA	Lactoferricin B	15	IC₅₀=45 µM
1115	16572423	FKCRRWQWRMKKLGA	Lactoferricin B	15	IC₅₀=60 µM
1256	10951191	GLFDIIKKIAESF	Aurein1.2	13	LC₅₀ = 10 µM
1265	10951191	GLFDIVKKVVGAFGSL	Aurein2.5	16	LC₅₀ = 10 µM
1274	10951191	GLFDIAKKVIGVIGSL	Aurein2.6	16	LC₅₀ = 10 µM
1283	10951191	GLFDIVKKIAGHIAGSI	Aurein 3.1	17	LC₅₀=10-100 µM
1292	10951191	GLFDIVKKIAGHIASSI	Aurein 3.2	17	LC₅₀ = 10 µM
1301	10951191	GLFDIVKKIAGHIVSSI	Aurein 3.3	17	LC₅₀ = 10 µM
1429	16269280	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	LD₅₀=1-4 µM
2858	22084165	KLlLKlLkkLLKlLKKK	Lytik	17	IC₅₀=77.3 µMol/L
2859	22084165	KLlLKlLkkLLKlLKKK	Lytik	17	IC₅₀=30.5 µMol/L
2865	22084165	KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK	IL-4RaÐlytic hybrid peptide	33	IC₅₀=18.5 µMol/L
2866	22084165	KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK	IL-4RaÐlytic hybrid peptide	33	IC₅₀=6.8 µMol/L
2907	21849092	KLlLKlLkkLLKlLKKK	Lytik	17	IC₅₀= 19.1 µM
2908	21849092	KLlLKlLkkLLKlLKKK	Lytik	17	IC₅₀= 21.9 µM
2909	21849092	KLlLKlLkkLLKlLKKK	Lytik	17	IC₅₀= 17.0 µM
2919	21849092	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	IC₅₀= 6.3 µM
2920	21849092	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	IC₅₀= 7.8 µM
2921	21849092	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	IC₅₀=7.0 µM
3129	23770440	FLGMIPGLIGGLISAFK	TsAP-2	17	IC₅₀ = 15.4 µM
3134	23770440	FLSLIPKLVKKIIKAFK	TsAP-S1	17	IC₅₀ = 2.9 µM
3139	23770440	FLGMIPKLIKKLIKAFK	TsAP-S2	17	IC₅₀ = 2.0 µM
3307	21453492	WKKW-Dip-KKWK	LTX-302	9	IC₅₀ =28 ± 0 µM
3310	21453492	KKWWKKW-Dip-K	LTX-315	9	IC₅₀ =14 ± 1 µM
3313	21453492	OOW-Dip-OOWWO	LTX-318	9	IC₅₀ =78 ± 7 µM
3316	21453492, 23533710	FKCRRWQWRMKK	LfcinB	12	IC₅₀ =141 ± 3 µM
3828	23034893	MDSNKDERAYAQWVIIILHNVGSSPFKIANLGLSWGKLYADGNKDKEVYP SDYNGKTVGPDEKIQINSCGRENASSGTEGSFDIVDPNDGNKTIRHFYWECPWGS KRNTWTPSGSNTKWMVEWSGQNLDSGALGTITVDVLRKGN	AAD (or Aa-Pri1)	145	At 2.5 µM concentration,decrease in cell vibility= 70%
4033	12631273, 9266696	GLFDVIKKVASVIGGL	Citropin 1.1	16	IC₅₀= 5 M
4042	12631273, 9266696	glfdvikkvasviggl	Citropin 1.1D	16	IC₅₀= 5 M
4051	12631273, 9266696	GLFAVIKKVASVIGGL	3	16	IC₅₀= 6 M
4060	12631273, 9266696	GLFDVIKAVASVIGGL	5	16	IC₅₀= 5 M
4069	12631273, 9266696	GLFDVIKKVAAVIGGL	7	16	IC₅₀= 5 M
4078	12631273, 9266696	GLFDVIKKVASVIKGL	11	16	IC₅₀= 5 M
4087	12631273, 9266696	GLFDVIKKVASVIKKL	13	16	IC₅₀= 5 M
4096	12631273, 9266696	GLFDVIAKVASVIKKL	14	16	IC₅₀= 5 M
4105	12631273, 9266696	GLFAVIKKVASVIKGL	15	16	IC₅₀= 5 M
4114	12631273, 9266696	GLFAVIKKVASVIKKL	16	16	IC₅₀= 5 M
4123	12631273, 9266696	GLFAVIKKVAAVIKKL	17	16	IC₅₀= 5 M
4132	12631273, 9266696	GLFAVIKKVAAVIRRL	18	16	IC₅₀= 5 M
4141	12631273, 9266696	GLFAVIKKVAKVIKKL	19	16	IC₅₀= 5 M
4150	12631273, 9266696	GLFKVIKKVASVIGGL	22	16	IC₅₀= 5 M
4159	12631273, 9266696	GLFKVIKKVAKVIKKL	23	16	IC₅₀= 5 M
4168	12631273, 9266696	LGGIVSAVKKIVDFLG	retro	16	IC₅₀= 5 M
4227	16568093	rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK	r8-BadBH3	35	0% apoptosis at 10 µM
4228	16568093	rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK	r8-BadBH3	35	10% apoptosis at 20 µM
4229	16568093	rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK	r8-BadBH3	35	30% apoptosis at 50 µM
4230	16568093	rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK	r8-BadBH3	35	30% apoptosis at 10 µM
4231	16568093	rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK	r8-BadBH3	35	80% apoptosis at 20 µM
4232	16568093	rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK	r8-BadBH3	35	80% apoptosis at 50 µM
4239	16568093	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	8% apoptosis at 10 µM
4240	16568093	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	45% apoptosis at 20 µM
4241	16568093	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	65% apoptosis at 50 µM
4242	16568093	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	25% apoptosis at 10 µM
4243	16568093	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	66% apoptosis at 20 µM
4244	16568093	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	68% apoptosis at 50 µM
4251	16568093	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	1% apoptosis at 10 µM
4252	16568093	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	2% apoptosis at 20 µM
4253	16568093	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	3% apoptosis at 50 µM
4254	16568093	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	2% apoptosis at 10 µM
4255	16568093	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	1% apoptosis at 20 µM
4256	16568093	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	5% apoptosis at 50 µM
4337	None	YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK	EB-Lytic	32	IC₅₀= 12 µM
4343	None	YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK	EB(H2R)-lytic	32	IC₅₀= 8.4 µM

CancerPPD :Database of Anticancer peptides and Proteins

Browse Result page of CancerPPD